NCT06822738 - A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma | Biotech Hunter

Enrollment

130

Participants

Timeline

Start Date

February 11, 2025

Primary Completion Date

November 30, 2028

Study Completion Date

November 30, 2028

Conditions

Primary Open Angle Glaucoma

Interventions

DEVICE

XEN63 Glaucoma Treatment System

Gel Stent

Trial Locations (15)

19004

RECRUITING

Ophthalmic Partners of PA /ID# 276059, Bala-Cynwyd

19107

RECRUITING

Wills Eye Hospital Glaucoma Dept /ID# 268569, Philadelphia

24016

RECRUITING

Vistar Eye Center - Roanoke - South Jefferson Street /ID# 276119, Roanoke

30076

RECRUITING

Coastal Research Associates - Roswell /ID# 268458, Roswell

32960

RECRUITING

New Vision Eye Center /ID# 269955, Vero Beach

55431

RECRUITING

Minnesota Eye Consultants - Minneapolis /ID# 272445, Minneapolis

66213

RECRUITING

Stiles Eyecare Excellence & Glaucoma Institute /ID# 268451, Overland Park

68137

RECRUITING

Vance Thompson Vision - Omaha /ID# 271599, Omaha

73112

RECRUITING

Oklahoma Eye Surgeons /ID# 269174, Oklahoma City

75231

RECRUITING

Glaucoma Associates Of Texas /ID# 268745, Dallas

75390

RECRUITING

UT Southwestern Medical Center /ID# 268571, Dallas

79902

RECRUITING

El Paso Eye Surgeons /ID# 268356, El Paso

80045

RECRUITING

University Of Colorado - Anschutz Medical Campus /ID# 269947, Aurora

85306

RECRUITING

Arizona Advanced Eye Research Institute /ID# 268363, Glendale

90232

RECRUITING

LA Glaucoma Group /ID# 268444, Culver City